JPMorgan Chase & Co. increased its stake in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 2.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 34,518 shares of the medical instruments supplier’s stock after acquiring an additional 761 shares during the quarter. JPMorgan Chase & Co. owned approximately 0.93% of Utah Medical Products worth $2,577,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Acrospire Investment Management LLC lifted its stake in shares of Utah Medical Products by 339.1% in the second quarter. Acrospire Investment Management LLC now owns 1,919 shares of the medical instruments supplier’s stock valued at $139,000 after buying an additional 1,482 shares in the last quarter. Prudential Financial Inc. bought a new position in shares of Utah Medical Products in the second quarter valued at $233,000. The Manufacturers Life Insurance Company lifted its stake in shares of Utah Medical Products by 15.4% in the second quarter. The Manufacturers Life Insurance Company now owns 3,355 shares of the medical instruments supplier’s stock valued at $242,000 after buying an additional 448 shares in the last quarter. OxFORD Asset Management LLP bought a new position in shares of Utah Medical Products in the second quarter valued at $267,000. Finally, Citigroup Inc. lifted its stake in shares of Utah Medical Products by 16.9% in the second quarter. Citigroup Inc. now owns 3,750 shares of the medical instruments supplier’s stock valued at $272,000 after buying an additional 541 shares in the last quarter. 66.67% of the stock is currently owned by institutional investors and hedge funds.
Separately, BidaskClub upgraded shares of Utah Medical Products from a “hold” rating to a “buy” rating in a report on Wednesday, December 6th.
The company also recently announced a quarterly dividend, which was paid on Wednesday, January 3rd. Stockholders of record on Friday, December 15th were issued a $0.27 dividend. The ex-dividend date was Thursday, December 14th. This represents a $1.08 annualized dividend and a dividend yield of 1.34%. This is an increase from Utah Medical Products’s previous quarterly dividend of $0.27. Utah Medical Products’s dividend payout ratio is currently 29.35%.
WARNING: “Utah Medical Products, Inc. (UTMD) Shares Bought by JPMorgan Chase & Co.” was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this report on another website, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The correct version of this report can be read at https://www.com-unik.info/2018/01/07/utah-medical-products-inc-utmd-shares-bought-by-jpmorgan-chase-co.html.
Utah Medical Products Profile
Utah Medical Products, Inc (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts.
Want to see what other hedge funds are holding UTMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Utah Medical Products, Inc. (NASDAQ:UTMD).
What are top analysts saying about Utah Medical Products? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Utah Medical Products and related companies.